November 18, 2025
03:00 PM BST / 10:00 AM EST
Virtual
Transform regulatory updates into business value. Most regulatory teams excel at surveillance but struggle with activation. Join Chris Whalley from Pfizer and industry experts as they reveal how leading organizations bridge the gap between regulatory intelligence and measurable business outcomes.
Most regulatory teams excel at tracking updates but struggle to turn them into measurable outcomes. Our Regulatory Intelligence Forum will show you how to move from monitoring information to activating it, with structure, speed, and accountability. Join Chris Whalley, Senior Director and Head of Global Regulatory Intelligence and Analysis at Pfizer, and industry experts as they share practical frameworks that help organizations connect intelligence to business impact.
Sr. Director and Head of Global Regulatory Intelligence & Analysis
Chris leads regulatory intelligence activities across Pfizer. A new medicine veteran with 25 years’ experience building regulatory affairs and intelligence solutions that accelerate the delivery of novel drugs and devices to patients. Chris leads the team who deliver actionable insights for regulatory strategists, advancing product development and lifecycle with reduced time to market. Chris is the current Chair of RAPS Regulatory Convergence Planning Committee and the Recipient of RAPS Community Leadership Award 2023.
Global Policy & Intelligence Lead
Rüdiger has a strong background in regulatory affairs comprising regulatory development and life-cycle management, label management, regulatory information and submission management encompassing expertise from affiliate and headquarter perspective with more than 25 years of experience. In his current position, he leads the Policy and Intelligence unit within UCB, Regulatory Community Excellence.